Related Experiment Video
Updated: Nov 18, 2025

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Growth failure: 'idiopathic' only after a detailed diagnostic evaluation
Robert Rapaport1, Jan M Wit2, Martin O Savage3
1Division of Pediatric Endocrinology & Diabetes, Mount Sinai Kravis Children's Hospital and Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Idiopathic short stature (ISS) and small for gestational age (SGA) labels are not definitive diagnoses. A combination of clinical evaluation, hormonal testing, and genetic sequencing is crucial for understanding short stature causes.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Growth Disorders
Background:
- Idiopathic short stature (ISS) and small for gestational age (SGA) are historical diagnostic labels for short children.
- While growth hormone (GH) treatment approvals in 2001-2003 solidified ISS and SGA as clinical entities, their diagnostic limitations persist.
- The emergence of genetic investigations has revealed numerous molecular insights into ISS and SGA.
Purpose of the Study:
- To challenge the definitive nature of ISS and SGA diagnostic labels.
- To advocate for a comprehensive approach to diagnosing short stature.
- To highlight the importance of integrating clinical, hormonal, and genetic data.
Main Methods:
- Review of historical definitions and diagnostic evolution of ISS and SGA.
- Analysis of the impact of molecular discoveries on understanding short stature.
- Proposal for a multi-disciplinary diagnostic hierarchy.
Main Results:
- ISS and SGA labels, originating before molecular genetics, are not exhaustive diagnostic categories.
- Genetic investigations have significantly advanced the understanding of underlying causes for short stature.
- Current diagnostic practices may not fully capture the etiology of short stature.
Conclusions:
- ISS and SGA should not be considered definitive diagnoses.
- A balanced integration of clinical evaluation, hormonal investigation, and genetic sequencing is essential.
- This multi-faceted approach will improve the identification of the true pathogenesis in patients with short stature.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Microbial Growth Measurement: Indirect Methods
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Nature and Nurture
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

